Simultaneous determination of estradiol and medroxyprogesterone acetate in pharmaceutical formulations by second-derivative spectrophotometry

This paper reports a simple and fast method for the simultaneous determination of estradiol (ED) and medroxyprogesterone acetate (MP) in pharmaceutical formulations by second-derivative spectrophotometry. Methanol was used to extract the drugs from formulations, and subsequently the extracts were evaluated directly by derivative spectrophotometry. The drugs were determined simultaneously by using the graphic method at 297.4 nm for ED and the zero-crossing method at 273.4 nm for MP. If both compounds are present together in a sample, it is possible to quantitate one in the presence of the other. The best signal-to-noise ratio was found when the second derivative of the spectrum was used. The linear ranges for determination of the drugs were 4.7 x 10(-6) to 1.6 x 10(-4) and 7.2 x 10(-6) to 2.0 x 10(-4) mol/L for ED and MP, respectively. The ingredients commonly found in commercial pharmaceutical formulations do not interfere with the determination. Chemical and spectral variables were optimized for the determination of both analytes. Good levels of repeatability (relative standard deviation), 1.4 and 1.9%, were obtained for ED and MP, respectively. The proposed method was applied to the determination of these drugs in pharmaceutical formulations.     

Simultaneous determination of dapsone and pyrimethamine by derivative spectrophotometry in pharmaceutical formulations

A simple and fast method was developed for the simultaneous determination of dapsone and pyrimethamine by first-order digital derivative spectrophotometry. Acetonitrile was used as a solvent to extract the drugs from the pharmaceutical formulations, and the samples were subsequently evaluated directly by digital derivative spectrophotometry. The simultaneous determination of both drugs was performed by the zero-crossing method at 249.4 and 231.4 nm for dapsone and pyrimethamine, respectively. The best signal-to-noise ratio was obtained when the first derivative of the spectrum was used. The linear range of determination for the drugs was from 6.6 x 10(-7) to 2.0 x 10(-4) and from 2.5 x 10(-6) to 2.0 x 10(-4) mol/L for dapsone and pyrimethamine, respectively. The excipients of commercial pharmaceutical formulations did not interfere in the analysis. Chemical and spectral variables were optimized for determination of both analytes. A good level of repeatability, 0.6 and 1.7% for dapsone and pyrimethamine, respectively, was observed. The proposed method was applied for the simultaneous determination of both drugs in pharmaceutical formulations.     

Simultaneous determination of N-butylscopolamine and oxazepam in pharmaceutical formulations by first-order digital derivative spectrophotometry

A simple method has been developed for the simultaneous determination of N-butylscopolamine bromide and oxazepam in pharmaceutical formulations using first-order digital derivative spectrophotometry. Acetonitrile was selected as the solvent in which both compounds showed well-defined bands. Both analytes showed good stability in this solvent when solutions of the analytes were exposed to light and temperatures between 20 degrees and 80 degrees C. The simultaneous determination of both drugs was performed by the zero-crossing method at 226.0 and 257.0 nm for N-butylscopolamine and oxazepam, respectively. The linear range of determination was found to be 2.5 x 10(-7) to 8.0 x 10(-5) mol/L for N-butylscopolamine and 7.1 x 10(-8) to 8.0 x 10(-5) mol/L for oxazepam. A very good level of repeatability (relative standard deviation) of 0.2% was observed for N-butylscopolamine and oxazepam. The ingredients commonly found in pharmaceutical formulations do not interfere. The proposed method was applied to the determination of these drugs in pharmaceutical formulations (capsules).     

Estimation of cephalosporin antibiotics by differential pulse polarography

Differential pulse polarographic (DPP) method of determination of cephalosporins has been developed based on the electrochemistry of the azomethine group in the drugs in universal buffers of pH 2.0-12.0. Quantitative measurements were successful in the concentration range of 1.0 x 10(-5) M-2.5 x 10(-8) M, the lower concentration representing the detection limit by DPP. The described procedure has been applied for the determination of these drugs individually in pharmaceutical formulations and urine samples as well as for simultaneous determination in a single run.     

Simultaneous determination of calcium and magnesium by derivative spectrophotometry in pharmaceutical products

First- and second-derivative spectrophotometric methods for the simultaneous determination of calcium and magnesium in their mixtures are described. The methods are based on the colored complexes formed by calcium and magnesium with bromopyrogallol red in presence of Tween 80 as a surfactant. The zero-crossing method has been utilized to measure the first- and second-derivative value of the derivative spectrum. Calcium (0.8-4.8microgml(-1)) is determined in the presence of magnesium (0.5-3.5microgml(-1)) at the pH 10 and vice versa at zero-crossing wavelengths of 544.5 and 570nm in the first-derivative procedure and 574 and 531nm in the second-derivative procedure, respectively. The detection limits achieved were 0.0575microgml(-1) of calcium and 0.03microgml(-1) of magnesium. The relative standard deviations were in all instances less than 2%. The proposed method has been applied to the simultaneous determination of calcium and magnesium in different samples: commercial multivitamin, human serum and drinking water where excellent agreement between reported and obtained results was achieved.     

Sequential determination of salicylic and acetylsalicylic acids by amperometric multisite detection flow injection analysis

An amperometric multisite detection flow injection analysis (FIA) system was developed for sequential determination of 2 analytes with a single sample injection and single detector. Tubular composite carbon electrodes with an inner diameter similar to that of the FIA manifold tubing were constructed so that measurements could be made without impairing the sample plug hydrodynamic characteristics. The electrochemical behavior of the tubular voltammetric cell in a low-dispersion FIA manifold and the behavior of the FIA system incorporating this type of voltammetric cell intended for multisite detection were evaluated by performing measurements with potassium hexacyanoferrate(II). Feasibility of the approach was demonstrated in the sequential determination of salicylic and acetylsalicylic acids in pharmaceutical products at a fixed potential of 0.98 V. The system allows sequential determination of salicylic acid concentrations ranging from 1.0 x 10(-5) to 5.0 x 10(-5) M and acetylsalicylic acid concentrations between 1.0 x 10(-3) and 5.0 x 10(-3) M with good precision on both detection sites and with relative standard deviations (RSDs) > or = 1.5% (n = 10) and 2.1% (n = 10), respectively. A comparison of these results with those of the U.S. Pharmacopeia procedure showed RSDs <5.0 and 1.0% for salicylic acid and acetylsalicylic acid, respectively. The proposed method enables 15 determinations per hour, which corresponds to the analysis of approximately 8 samples per hour. The detection limits of the methodology were approximately 3.5 x 10(-6) and 1.1 x 10(-5) M, respectively, for the first and second monitoring sites.     

Derivative spectrophotometric determination of sulphonamides by the Bratton-Marshall reaction

A modified method for the determination of sulphonamides, based on the Bratton-Marshall reaction with derivative spectrophotometry, is proposed. Diverse sulphonamides are determined with excellent precision by using first- to fourth-order derivative spectra. The method was applied for the determination of sulphonamides in urine, honey and pharmaceutical formulations without pretreatment of the samples.     

Flow injection turbidimetric determination of thiamine in pharmaceutical formulations using silicotungstic acid as precipitant reagent

A simple flow injection system is proposed for the determination of thiamine in pharmaceutical formulations. The determination is based on the precipitation reaction of thiamine with silicotungstic acid in acidic medium to form a thiamine silicotungstate suspension that is measured at 420 nm. Adding 0.05% (w/v) poly(ethyleneglycol) in the carrier solution (0.5 mol l(-1) hydrochloric acid), an improvement in the sensitivity, repeatability and baseline stability of the flow injection system was obtained. The calibration graph was linear in the thiamine concentration range from 5.0x10(-5) to 3.0x10(-4) mol l(-1) with a detection limit of 1.0x10(-5) mol l(-1). The relative standard deviations for ten successive measurements of 1.0x10(-4) mol l(-1) and 2.5x10(-4) mol l(-1) thiamine were less than 1% and an analytical frequency of 90 h(-1) was obtained.     

Carbon paste electrode modified with copper(II) phosphate immobilized in a polyester resin for voltammetric determination of <Emphasis Type="SmallCaps"> l </Emphasis>-ascorbic acid in pharmaceutical formulations

A carbon paste electrode modified with copper(II) phosphate immobilized in a polyester resin (CuP-Poly) is proposed for voltammetric determination of L-ascorbic acid in pharmaceutical formulations. The modified electrode allows the detection of L-ascorbic acid at lower anodic potentials than observed at unmodified electrodes. Several parameters that can influence the voltammetric response of the proposed electrode such as carbon paste composition, pH, scan rate, and possible interference were investigated. The peak current was proportional to the concentration of ascorbic acid in the range 2.0 x 10(-5) to 3.2 x 10(-3) mol L(-1) with a detection limit of 1.0 x 10(-5) mol L(-1). The stability and repeatability of the electrode for the determination of L-ascorbic acid are also discussed. Amperometric response was also recorded for electrocatalytic oxidation of the L-ascorbic acid. Concentrations of the vitamin C in pharmaceutical formulations (tablets) measured using the modified electrode and a titrimetric method are in agreement at the 95% confidence level and within an acceptable range of error.     

Simultaneous determination of aluminium and iron in glasses,phosphate rocks and cement using first- and second-derivative spectrophotometry

First- and second-derivative spectrophoto-metric methods for the simultaneous determination of aluminium and iron in their mixtures are described. The methods are based on the colored complexes formed by aluminium and iron with hematoxylin in the presence of cetyltrimethylammonium bromide as a surfactant. The zero-crossing method has been utilized to measure the first- and second-derivative value of the derivative spectrum. Aluminium (0.05-1 microg ml(-1)) could be determined in the presence of iron (0.09-1.6 microg ml(-1)) and vice versa. The detection limits of aluminium and iron are 0.01 and 0.09 microg ml(-1), respectively in the first-derivative mode and 0.014 and 0.1 microg ml(-1) in the second-derivative mode. The proposed method has been applied to the simultaneous determination of aluminium and iron in glasses, phosphate rocks, cement and magnesite alloy.     

Analysis of mixtures of purines and pyrimidines by first- and second-derivative ultraviolet spectrometry

Zero-order, first-derivative and second-derivative ultraviolet absorption spectra of a series of purines, pyrimidines and their binary mixtures in aqueous solution have been recorded at 298 K. It is shown that second-derivative spectra can be used for the identification of eight mixtures of purines and pyrimidines. Several graphical procedures are tested for evaluating derivative spectra in quantitative measurements of single compounds and mixtures. Linear log-log calibration plots are obtained with correlation coefficients generally larger than 0.99. Second-derivative spectra appear to provide a precise and simple method for determination of purines and pyrimidines, at concentrations ranging between 5 x 10(-6) and 5 x 10(-4)M.     

Optical detection of phenolic compounds based on the surface plasmon resonance band of Au nanoparticles

An indirect colorimetric method is presented for detection of trace amounts of hydroquinone (1), catechol (2) and pyrogallol (3). The reduction of AuCl4(-) to Gold nanoparticles (Au-NPs) by these phenolic compounds in the presence of cetyltrimethylammonium chloride (CTAC) produced very intense surface plasmon resonance peak of Au-NPs. The plasmon absorbance of Au-NPs allows the quantitative colorimetric detection of the phenolic compounds. The calibration curves derived from the changes in absorbance at lambda = 568 nm were linear with concentration of hydroquinone, catechol and pyrogallol in the range of 7.0 x 10(-7) to 1.0 x 10(-4)M, 6.0 x 10(-6) to 2.0 x 10(-4)M and 6.0 x 10(-7) to 1.0 x 10(-4)M, respectively. The detection limits were 5.3 x 10(-7), 2.5 x 10(-6) and 3.2 x 10(-7)M for the hydroquinone, catechol and pyrogallol, respectively. The method was applied satisfactorily to the determination of phenolic compounds in water samples and pharmaceutical formulations.     

The Use of Internal Standard Method for Dertvative-Spectrophotometric Determination of Chlorpromazine Hydrochloride

ABSTRACT

The use of 1, 10-phenantroline as internal standard (IS) is proposed for spectrophotometric determination of chlorpromazine hydrochloride in pharmaceutical formulations. The spectra of both compounds: analyte and internal standard are partially overlapped, so the Savitzky-Golay alghoritm was used to obtain separated signals of analyte and IS. The best parameters to generate the second-derivative spectra were: ∠λ = 10 nm (5 experimental points) and second polynomial degree. For quantification of chlorpromazine in pharmaceuticals, the zero-crossing technique was used. The values of the second-derivative peaks were measured for chlorpromazine at 256 nm and at 236 nm for IS. Analytical characteristic for proposed method was evaluated (r²=0.9990, detection limit=3.97 ng/ml). The obtained analytical results were in good agreement with results obtained using the UV-spectrophotometric Blazek method.     

Potentiometric sensors enabling fast screening of the benign prostatic hyperplasia drug alfuzosin in pharmaceuticals, urine and serum

The construction and characterization of potentiometric membrane electrodes are described for the quantification of alfuzosin, a drug used in a mono- and combined therapy of benign prostatic hyperplasia (BPH). The membranes of these electrodes consist of alfuzosin hydrochloride-tetraphenyl borate, (Az-TPB), chlorophenyl borate (Az-ClPB), and phosphotungstate (Az(3)-PT) ion associations as molecular recognition reagent dispersed in PVC matrix with dioctylpthalate as plasticizer. The performance characteristics of these electrodes, which were evaluated according to IUPAC recommendations, revealed a fast, stable and liner response for alfuzosin over the concentration ranges of 8.3 x 10(-6) to 1.0 x 10(-2) M, 3.8 x 10(-6) to 1.0 x 10(-2) M, 7.5 x 10(-7) to 1.0 x 10(-2) M AzCl with cationic slopes of 57.0, 56.0 and 58.5 mV/decade, respectively. The solubility product of the ion-pair and the formation constant of the precipitation reaction leading to the ion-pair formation were determined conductometrically. The electrodes, fully characterized in terms of composition, life span and usable pH range, were applied to the potentiometric determination of alfuzosin hydrochloride ion in different pharmaceutical preparations and biological fluids without any interference from excipients or diluents commonly used in drug formulations. The potentiometric method was also used in the determination of alfuzosin hydrochloride in pharmaceutical preparations in four batches with different expiration dates. Validation of the method showed suitability of the proposed electrodes for use in the quality control assessment of alfuzosin hydrochloride. This potentiometric method offers the advantages of high-throughput determination, simplicity, accuracy, automation feasibility, and applicability to turbid and colored sample solutions.     

Chronoamperometric determination of paracetamol using an avocado tissue (Persea americana) biosensor

A biosensor based on vaseline/graphite modified with avocado tissue (Persea americana) as the source of polyphenol oxidase was developed and used for the chronoamperometric determination of paracetamol in pharmaceutical formulations. This enzyme catalyses the oxidation of paracetamol to N-acetyl-p-benzoquinoneimine whose electrochemical reduction back to paracetamol was obtained at a potential of -0.12 V. After addition of paracetamol reference solutions in glass cell and stirring for 60 s for the accumulation of N-acetyl-p-benzoquinoneimine at the electrode surface under open-circuit conditions, the current response was monitored by 120 s without stirring. The currents obtained at 70 s were proportional to the paracetamol concentration from 1.2x10(-4) to 5.8x10(-3) mol l(-1) (r=0.9927) with a detection limit of 8.8x10(-5) mol l(-1). The recovery of paracetamol from two samples ranged from 97.9 to 100.7% and a relative standard deviation lower than 0.5% for a solution containing 5.0x10(-3) mol l(-1) paracetamol in 0.10 mol l(-1) phosphate buffer solution (pH 7.0; n=10) was obtained. The results obtained for paracetamol in pharmaceutical formulations using the proposed biosensor and those obtained using a pharmacopoeial procedure are in agreement at the 95% confidence level.     

Mebendazole selective membrane sensor and its application to pharmaceutical analysis.

A PVC membrane sensor for the selective determination of mebendazole (MBZ) was fabricated. The sensor is based on an ion association of MBZ with silicotungstic acid (STA) as ion pair and bis(2-ethylhexyl)phthalate (BEP) as the plasticizing agent in a PVC matrix. The sensor showed a linear response for MBZ for a concentration range 1.0x10(-6)-5.0x10(-2) M with a Nernstian slope of 55.8 mV/decade (limit of detection 6.3x10(-7) M) in the pH range 4-7. It has a fast response time of <30 s. The sensor showed a very good selectivity for MBZ with respect to a large number of ions. The direct determination of MBZ in pharmaceutical formulations gave results that compare well with the data obtained from the standard method.     

Spectrophotometric determination of fluoxetine by batch and flow injection methods

A rapid, simple, and accurate spectrophotometric method is presented for the determination of fluoxetine by batch and flow injection analysis methods. The method is based on fluoxetine competitive complexation reaction with phenolphthalein-beta-cyclodextrin (PHP-beta-CD) inclusion complex. The increase in the absorbance of the solution at 554 nm by the addition of fluoxetine was measured. The formation constant for fluoxetin-beta-CD was calculated by non-linear least squares fitting. Fluoxetine can be determined in the range 7.0 x 10(-6)-2.4 x 10(-4) mol l(-1) and 5.0 x 10(-5)-1.0 x 10(-2) mol l(-1) by batch and flow methods, respectively. The limit of detection and limit of quantification were respectively 4.13 x 10(-6) mol l(-1) and 1.38 x 10(-5) mol l(-1) for batch and 2.46 x 10(-5) mol l(-1) and 8.22 x 10(-5) mol l(-1) for flow method. The sampling rate in flow injection analysis method was 80+/-5 samples h(-1). The method was applied to the determination of fluoxetine in pharmaceutical formulations and after addition to human urine samples.     

Second-Derivative Spectrophotometric Determination of Some Benzenoid Drugs

Abstract

A rapid second-derivative spectrophotometric assay procedure has been described for the determination of some benzenoid drugs in pharmaceutical dosage forms. Spectral interference from formulation excipients in simple uv spectrophotometric methods has been eliminated by the application of the proposed method. The different assay parameters, linearity and precision of the method have been assessed. The assay results obtained for eight batches of the pharmaceutical formulations of these drugs are in accord with the declared amounts. The high specificity, ease and simplicity offered by second-derivative spectrophotometry permit unit dose assay of these formulations.     

Potentiometric sensor for the high throughput determination of tetramisole hydrochloride

The electrochemical response characteristics of poly(vinyl)chloride (PVC) based membrane sensors for determination of tetramisole hydrochloride (TmCl) is described. The membranes of these electrodes consist of tetramisole-tetraphenyl borate (Tm-TPB), chlorophenyl borate (Tm-ClPB), and phosphotungstate (Tm(3)-PT) ion associations dispersed in a PVC matrix with dibutylpthalate as a plasticizer. The electrodes were fully characterized in terms of composition, life span, usable pH range, and working concentration range and ionic strength. The electrodes showed Nernstian response over the concentration ranges of 7.4 x 10(-7) to 1.0 x 10(-2) M, 1.7 x 10(-6) to 1.0 x 10(-2) M, and 5.6 x 10(-6) to 1.0 x 10(-2) M TmCl, respectively, and were applied to the potentiometric determination of tetramisole ion in pure solutions and pharmaceutical preparations. The potentiometric determination was also used in the determination of tetramisole in pharmaceutical preparations in four batches of different expiration dates. The electrodes exhibited good selectivity for TmCl with respect to a large number of excipients such as inorganic cations, organic cations, amino acids, and sugars. The solubility product of the ion-pair and the formation constant of the precipitation reaction leading to the ion-pair formation were determined conductometrically. The new potentiometric method offers the advantages of high-throughput determination, simplicity, accuracy, automation feasibility, and applicability to turbid and colored sample solutions.     

Colorimetric determination of benzocaine, lignocaine and procaine hydrochlorides in pure form and in pharmaceutical formulations using p-benzoquinone.

A simple, accurate and sensitive method for the microdetermination of benzocaine, lignocaine and procaine hydrochlorides in pure forms and in pharmaceutical formulations is described. The procedure is based on the reaction of those drugs in an aqueous acidic medium with p-benzoquinone to form charge-transfer complexes. The method has been used for the determination of 5.0-70, 5.0-60 and 5.0-90 microg ml(-1) of benzocaine, lignocaine HCl and procaine HCl, respectively. The complexes have apparent molar absorptivities of 1.70 x 10(3), 2.79 x 10(3) and 2.42 x 10(3) L mol(-1) cm(-1) and Sandell sensitivities of 9.72, 10.34 and 11.25 ng cm(-2), respectively. The proposed procedure of analysis is as accurate as the British Pharmacopoeial method (2003). The method was successfully used for the determination of those drugs in the presence of their degradation products, additives and excipients, which were normally encountered in pharmaceutical formulations.